The Healthcare Investor

Latest from The Healthcare Investor

Beecken Petty O’Keefe & Company (BPOC) has announced it will sell Cranial Technologies to Eurazeo.

Cranial Technologies, based in Tempe, Ariz., is a developer, manufacturer and provider of custom cranial orthotics for treating infants with plagiocephaly. Founded in 1986, the company manufactures the DOC Band, a custom cranial orthotic.

BPOC, based in Chicago,

Francisco Partners will acquire data and analytics assets from IBM that are currently part of its Watson Health business, according to a news release.

Assets that will be acquired by Francisco Partners reportedly include Health Insights, MarketScan, Clinical Development, Social Program Management, Micromedex and imaging software offerings.

Francisco Partners, with its U.S. headquarters

Nautic Partners has made a strategic growth investment in SPS Health, according to a news release.

SPS, based in Milwaukee, offers a portfolio of solutions, including formulary management, on-demand pharmacy and benefit administration, to pharmacies and pharmacy benefit managers. Services are provided through SPS’s three companies: LithiaRx, Trinity Healthcare Solutions and StatimRx.

Nautic

Great Point Partners (GPP) has acquired Performance Cell Manufacturing (PCM), according to a news release.

PCM, based in San Diego and founded in 2002, is a contract development and manufacturing organization of cell therapy products for biopharmaceutical companies.

As part of the transaction, PCM is changing its name to Cellipont Bioservices.

GPP,

Lee Equity Partners has announced it has invested in Therapy Partner Solutions (TPS).

TPS, based in Fernandina Beach, Fla., delivers physical therapy services across three divisions: clinic partnership, management services and performance solutions. Founded in 2017, TPS states that its family of companies has offices in nine states and services clients in nearly all

One Equity Partners (OEP) has announced it has completed a strategic investment of InfuCare Rx

InfuCare Rx, based in Fairfield, N.J., is a national provider of specialty infusion therapies and comprehensive clinical therapy management services to patients with complex conditions. Founded in 2015, the company reports servicing more than 4,000 patients across 43 states.

OEP

WindRose Health Investors has announced it has completed the recapitalization of Terrapin Pharmacy.

Terrapin, based in Annapolis, Md., is a specialized pharmacy primarily serving individuals diagnosed with severe and persistent mental illnesses in the Mid-Atlantic region. Founded in 2005, the company states it serves skilled nursing and rehabilitation facilities, assisted living facilities and